Literature DB >> 21468220

Lysozyme promotes the release of Toll-like receptor-2 stimulants from gram-positive but not gram-negative intestinal bacteria.

Clett Erridge1.   

Abstract

Entities:  

Keywords:  gut microbiota; inflammation; inflammatory bowel disease; lysozyme; pathogen-associated molecular patterns; toll-like receptors

Mesh：

Substances：

Year:  2010        PMID： 21468220      PMCID： PMC3056103          DOI： 10.4161/gmic.1.6.13726

Source DB:  PubMed          Journal:  Gut Microbes        ISSN： 1949-0976


× No keyword cloud information.
  26 in total

1.  Pathophysiological role of Toll-like receptor 5 engagement by bacterial flagellin in colonic inflammation.

Authors:  Sang Hoon Rhee; Eunok Im; Martin Riegler; Efi Kokkotou; Michael O'brien; Charalabos Pothoulakis
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-12       Impact factor: 11.205

2.  Role of toll-like receptors in spontaneous commensal-dependent colitis.

Authors:  Seth Rakoff-Nahoum; Liming Hao; Ruslan Medzhitov
Journal:  Immunity       Date:  2006-08-03       Impact factor: 31.745

3.  Symbiotic bacteria direct expression of an intestinal bactericidal lectin.

Authors:  Heather L Cash; Cecilia V Whitham; Cassie L Behrendt; Lora V Hooper
Journal:  Science       Date:  2006-08-25       Impact factor: 47.728

4.  Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease.

Authors:  Alexander Swidsinski; Jutta Weber; Vera Loening-Baucke; Laura P Hale; Herbert Lochs
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

5.  Humoral immune response to flagellin requires T cells and activation of innate immunity.

Authors:  Catherine J Sanders; Yimin Yu; Daniel A Moore; Ifor R Williams; Andrew T Gewirtz
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

6.  Fecal lysozyme in assessment of disease activity in inflammatory bowel disease.

Authors:  A van der Sluys Veer; J Brouwer; I Biemond; G E Bohbouth; H W Verspaget; C B Lamers
Journal:  Dig Dis Sci       Date:  1998-03       Impact factor: 3.199

7.  MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis.

Authors:  Akihiro Araki; Takanori Kanai; Takahiro Ishikura; Shin Makita; Koji Uraushihara; Ryoichi Iiyama; Teruji Totsuka; Kiyoshi Takeda; Shizuo Akira; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2005-01       Impact factor: 7.527

8.  Clinical relevance of lysozyme in the faeces.

Authors:  M H Hemrika; G M Costongs; L G Engels; L P Bos; P C Janson; J A Flendrig
Journal:  Neth J Med       Date:  1989-04       Impact factor: 1.422

9.  Lysozyme regulates LPS-induced interleukin-6 release in mice.

Authors:  K Takada; N Ohno; T Yadomae
Journal:  Circ Shock       Date:  1994-12

10.  Detoxification of lipopolysaccharide (LPS) by egg white lysozyme.

Authors:  K Takada; N Ohno; T Yadomae
Journal:  FEMS Immunol Med Microbiol       Date:  1994-10
View more
  3 in total

1.  Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy.

Authors:  Jasmohan S Bajaj; Naga S Betrapally; Phillip B Hylemon; Douglas M Heuman; Kalyani Daita; Melanie B White; Ariel Unser; Leroy R Thacker; Arun J Sanyal; Dae Joong Kang; Masoumeh Sikaroodi; Patrick M Gillevet
Journal:  Hepatology       Date:  2015-05-06       Impact factor: 17.425

2.  TLR signaling in human antigen-presenting cells regulates MR1-dependent activation of MAIT cells.

Authors:  James E Ussher; Bonnie van Wilgenburg; Rachel F Hannaway; Kerstin Ruustal; Prabhjeet Phalora; Ayako Kurioka; Ted H Hansen; Christian B Willberg; Rodney E Phillips; Paul Klenerman
Journal:  Eur J Immunol       Date:  2016-05-30       Impact factor: 5.532

3.  Effects of over-expression of TLR2 in transgenic goats on pathogen clearance and role of up-regulation of lysozyme secretion and infiltration of inflammatory cells.

Authors:  Shoulong Deng; Kun Yu; Baolu Zhang; Yuchang Yao; Yufeng Liu; Haijuan He; Hongtao Zhang; Maosheng Cui; Juncai Fu; Zhengxing Lian; Ning Li
Journal:  BMC Vet Res       Date:  2012-10-22       Impact factor: 2.741
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.